Medicure Inc. (OTCMKTS:MCUJF) Short Interest Update

Medicure Inc. (OTCMKTS:MCUJF) saw a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 1,500 shares, a growth of 650.0% from the February 28th total of 200 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 6,900 shares, the short-interest ratio is presently 0.2 days.

Medicure Price Performance

OTCMKTS MCUJF remained flat at $0.46 during trading hours on Friday. The firm has a market cap of $4.75 million, a PE ratio of -3.25 and a beta of 0.87. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.03 and a quick ratio of 1.64. Medicure has a 52-week low of $0.46 and a 52-week high of $0.92. The business has a 50 day moving average of $0.51 and a two-hundred day moving average of $0.62.

Medicure Company Profile

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.